nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—CYP2C18—Valproic Acid—migraine	0.0859	0.124	CbGbCtD
Lansoprazole—CYP2C18—Verapamil—migraine	0.0748	0.108	CbGbCtD
Lansoprazole—CYP1A1—Propranolol—migraine	0.0453	0.0653	CbGbCtD
Lansoprazole—ABCG2—Verapamil—migraine	0.0337	0.0485	CbGbCtD
Lansoprazole—CYP2C19—Timolol—migraine	0.0246	0.0355	CbGbCtD
Lansoprazole—CYP2C8—Amitriptyline—migraine	0.0226	0.0326	CbGbCtD
Lansoprazole—CYP2C19—Propranolol—migraine	0.0219	0.0316	CbGbCtD
Lansoprazole—CYP2C8—Valproic Acid—migraine	0.0206	0.0297	CbGbCtD
Lansoprazole—CYP1A2—Propranolol—migraine	0.0202	0.0292	CbGbCtD
Lansoprazole—ABCB1—Timolol—migraine	0.0198	0.0286	CbGbCtD
Lansoprazole—CYP2C19—Amitriptyline—migraine	0.019	0.0273	CbGbCtD
Lansoprazole—CYP2D6—Timolol—migraine	0.0187	0.027	CbGbCtD
Lansoprazole—CYP2C8—Verapamil—migraine	0.0179	0.0259	CbGbCtD
Lansoprazole—ABCB1—Propranolol—migraine	0.0177	0.0255	CbGbCtD
Lansoprazole—CYP1A2—Amitriptyline—migraine	0.0175	0.0252	CbGbCtD
Lansoprazole—CYP2C19—Valproic Acid—migraine	0.0173	0.0249	CbGbCtD
Lansoprazole—CYP2D6—Propranolol—migraine	0.0167	0.024	CbGbCtD
Lansoprazole—CYP1A2—Valproic Acid—migraine	0.0159	0.023	CbGbCtD
Lansoprazole—CYP2C9—Amitriptyline—migraine	0.0158	0.0227	CbGbCtD
Lansoprazole—CYP2C19—Topiramate—migraine	0.0156	0.0225	CbGbCtD
Lansoprazole—ABCB1—Amitriptyline—migraine	0.0153	0.0221	CbGbCtD
Lansoprazole—CYP2C19—Verapamil—migraine	0.015	0.0217	CbGbCtD
Lansoprazole—CYP2D6—Amitriptyline—migraine	0.0144	0.0208	CbGbCtD
Lansoprazole—CYP2C9—Valproic Acid—migraine	0.0144	0.0207	CbGbCtD
Lansoprazole—CYP1A2—Verapamil—migraine	0.0139	0.02	CbGbCtD
Lansoprazole—CYP2C9—Verapamil—migraine	0.0125	0.018	CbGbCtD
Lansoprazole—ABCB1—Verapamil—migraine	0.0121	0.0175	CbGbCtD
Lansoprazole—CYP2D6—Verapamil—migraine	0.0114	0.0165	CbGbCtD
Lansoprazole—CYP3A4—Propranolol—migraine	0.0106	0.0153	CbGbCtD
Lansoprazole—CYP3A4—Amitriptyline—migraine	0.00916	0.0132	CbGbCtD
Lansoprazole—CYP3A4—Valproic Acid—migraine	0.00835	0.012	CbGbCtD
Lansoprazole—CYP3A4—Topiramate—migraine	0.00754	0.0109	CbGbCtD
Lansoprazole—CYP3A4—Verapamil—migraine	0.00727	0.0105	CbGbCtD
Lansoprazole—ATP4B—Ion transport by P-type ATPases—ATP1A2—migraine	0.00537	0.0985	CbGpPWpGaD
Lansoprazole—ATP4B—Ion transport by P-type ATPases—ATP1A3—migraine	0.00537	0.0985	CbGpPWpGaD
Lansoprazole—ATP4A—Ion transport by P-type ATPases—ATP1A2—migraine	0.00479	0.0878	CbGpPWpGaD
Lansoprazole—ATP4A—Ion transport by P-type ATPases—ATP1A3—migraine	0.00479	0.0878	CbGpPWpGaD
Lansoprazole—ATP4B—Ion channel transport—TRPM8—migraine	0.00245	0.045	CbGpPWpGaD
Lansoprazole—ATP4A—Ion channel transport—TRPM8—migraine	0.00219	0.0401	CbGpPWpGaD
Lansoprazole—ATP4B—Ion channel transport—ATP1A3—migraine	0.00186	0.0341	CbGpPWpGaD
Lansoprazole—ATP4B—Ion channel transport—ATP1A2—migraine	0.00186	0.0341	CbGpPWpGaD
Lansoprazole—ATP4A—Ion channel transport—ATP1A3—migraine	0.00166	0.0304	CbGpPWpGaD
Lansoprazole—ATP4A—Ion channel transport—ATP1A2—migraine	0.00166	0.0304	CbGpPWpGaD
Lansoprazole—ATP4B—Ion channel transport—HTR3A—migraine	0.00158	0.029	CbGpPWpGaD
Lansoprazole—ATP4A—Ion channel transport—HTR3A—migraine	0.00141	0.0258	CbGpPWpGaD
Lansoprazole—MAPT—Alzheimers Disease—LRP1—migraine	0.00115	0.0211	CbGpPWpGaD
Lansoprazole—MAPT—Notch Signaling Pathway—NOTCH4—migraine	0.00108	0.0199	CbGpPWpGaD
Lansoprazole—MAPT—Notch Signaling Pathway—NOTCH3—migraine	0.000921	0.0169	CbGpPWpGaD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—TRPM8—migraine	0.000853	0.0157	CbGpPWpGaD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—TRPM8—migraine	0.000761	0.014	CbGpPWpGaD
Lansoprazole—MAPT—LKB1 signaling events—ESR1—migraine	0.0007	0.0128	CbGpPWpGaD
Lansoprazole—CYP1B1—Estrogen Receptor Pathway—ESR1—migraine	0.00068	0.0125	CbGpPWpGaD
Lansoprazole—MAPT—IL-5 Signaling Pathway—FOS—migraine	0.000668	0.0123	CbGpPWpGaD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—ATP1A2—migraine	0.000647	0.0119	CbGpPWpGaD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—ATP1A3—migraine	0.000647	0.0119	CbGpPWpGaD
Lansoprazole—MAPT—IL-2 Signaling Pathway—FOS—migraine	0.000643	0.0118	CbGpPWpGaD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—ATP1A3—migraine	0.000576	0.0106	CbGpPWpGaD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—ATP1A2—migraine	0.000576	0.0106	CbGpPWpGaD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—HTR3A—migraine	0.00055	0.0101	CbGpPWpGaD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—HTR3A—migraine	0.00049	0.00899	CbGpPWpGaD
Lansoprazole—MAPT—Kit receptor signaling pathway—FOS—migraine	0.00049	0.00898	CbGpPWpGaD
Lansoprazole—MAPT—trigeminal ganglion—migraine	0.000483	0.127	CbGeAlD
Lansoprazole—MAPT—LPA receptor mediated events—FOS—migraine	0.000459	0.00842	CbGpPWpGaD
Lansoprazole—CYP1A1—Estrogen Receptor Pathway—ESR1—migraine	0.000419	0.00768	CbGpPWpGaD
Lansoprazole—ATP4A—neck—migraine	0.000415	0.109	CbGeAlD
Lansoprazole—MAPT—BDNF signaling pathway—BDNF—migraine	0.000355	0.00651	CbGpPWpGaD
Lansoprazole—CYP2C18—FOXA1 transcription factor network—ESR1—migraine	0.000348	0.00638	CbGpPWpGaD
Lansoprazole—ABCG2—Fluoropyrimidine Activity—MTHFR—migraine	0.00033	0.00606	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—TGFBR2—migraine	0.000326	0.00598	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—BDNF—migraine	0.000314	0.00575	CbGpPWpGaD
Lansoprazole—CYP2C18—FOXA1 transcription factor network—FOS—migraine	0.000313	0.00575	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.000283	0.00519	CbGpPWpGaD
Lansoprazole—CYP4A11—NRF2 pathway—SLC6A4—migraine	0.00028	0.00513	CbGpPWpGaD
Lansoprazole—CYP1A2—Estrogen Receptor Pathway—ESR1—migraine	0.000267	0.0049	CbGpPWpGaD
Lansoprazole—ATP4A—cardiovascular system—migraine	0.000259	0.0682	CbGeAlD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor—ESR1—migraine	0.000247	0.00454	CbGpPWpGaD
Lansoprazole—MAPT—BDNF signaling pathway—FOS—migraine	0.00024	0.0044	CbGpPWpGaD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—ESR1—migraine	0.000212	0.00389	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—FOS—migraine	0.000212	0.00389	CbGpPWpGaD
Lansoprazole—CYP4A11—NRF2 pathway—TGFBR2—migraine	0.000211	0.00387	CbGpPWpGaD
Lansoprazole—MAPT—cerebellum—migraine	0.000211	0.0555	CbGeAlD
Lansoprazole—MAPT—Alzheimers Disease—TNF—migraine	0.000208	0.00382	CbGpPWpGaD
Lansoprazole—CYP1A1—Oxidative Stress—FOS—migraine	0.000193	0.00354	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—TRPM8—migraine	0.000178	0.00326	CbGpPWpGaD
Lansoprazole—ATP4A—head—migraine	0.000175	0.0462	CbGeAlD
Lansoprazole—MAPT—brain—migraine	0.000171	0.0451	CbGeAlD
Lansoprazole—ATP4A—nervous system—migraine	0.000166	0.0438	CbGeAlD
Lansoprazole—ATP4A—central nervous system—migraine	0.00016	0.0421	CbGeAlD
Lansoprazole—ATP4A—cerebellum—migraine	0.000156	0.0412	CbGeAlD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor—ESR1—migraine	0.000152	0.00279	CbGpPWpGaD
Lansoprazole—ABCG2—HIF-1-alpha transcription factor network—FOS—migraine	0.000152	0.00279	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—ATP1A2—migraine	0.000135	0.00247	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—ATP1A3—migraine	0.000135	0.00247	CbGpPWpGaD
Lansoprazole—ATP4A—brain—migraine	0.000127	0.0335	CbGeAlD
Lansoprazole—Flatulence—Gabapentin—migraine	0.000125	0.000503	CcSEcCtD
Lansoprazole—Anaphylactic shock—Valproic Acid—migraine	0.000125	0.000503	CcSEcCtD
Lansoprazole—Oedema—Valproic Acid—migraine	0.000125	0.000503	CcSEcCtD
Lansoprazole—Bradycardia—Topiramate—migraine	0.000125	0.000502	CcSEcCtD
Lansoprazole—Pruritus—Verapamil—migraine	0.000125	0.000502	CcSEcCtD
Lansoprazole—Tension—Gabapentin—migraine	0.000124	0.000501	CcSEcCtD
Lansoprazole—Angioedema—Timolol—migraine	0.000124	0.000501	CcSEcCtD
Lansoprazole—Dysgeusia—Gabapentin—migraine	0.000124	0.0005	CcSEcCtD
Lansoprazole—Infection—Valproic Acid—migraine	0.000124	0.000499	CcSEcCtD
Lansoprazole—Nervousness—Gabapentin—migraine	0.000123	0.000496	CcSEcCtD
Lansoprazole—Rhinitis—Topiramate—migraine	0.000123	0.000495	CcSEcCtD
Lansoprazole—Back pain—Gabapentin—migraine	0.000123	0.000494	CcSEcCtD
Lansoprazole—Hepatitis—Topiramate—migraine	0.000123	0.000494	CcSEcCtD
Lansoprazole—Nervous system disorder—Valproic Acid—migraine	0.000122	0.000493	CcSEcCtD
Lansoprazole—Vertigo—Timolol—migraine	0.000122	0.000493	CcSEcCtD
Lansoprazole—Thrombocytopenia—Valproic Acid—migraine	0.000122	0.000492	CcSEcCtD
Lansoprazole—Syncope—Timolol—migraine	0.000122	0.000492	CcSEcCtD
Lansoprazole—Hypoaesthesia—Topiramate—migraine	0.000122	0.000491	CcSEcCtD
Lansoprazole—Hallucination—Topiramate—migraine	0.000122	0.000491	CcSEcCtD
Lansoprazole—Muscle spasms—Gabapentin—migraine	0.000122	0.000491	CcSEcCtD
Lansoprazole—Tachycardia—Valproic Acid—migraine	0.000122	0.000491	CcSEcCtD
Lansoprazole—Vomiting—Propranolol—migraine	0.000122	0.00049	CcSEcCtD
Lansoprazole—Pharyngitis—Topiramate—migraine	0.000122	0.00049	CcSEcCtD
Lansoprazole—MAPT—Apoptosis—TNF—migraine	0.000122	0.00223	CbGpPWpGaD
Lansoprazole—Skin disorder—Valproic Acid—migraine	0.000121	0.000488	CcSEcCtD
Lansoprazole—Urinary tract disorder—Topiramate—migraine	0.000121	0.000487	CcSEcCtD
Lansoprazole—Oedema peripheral—Topiramate—migraine	0.000121	0.000486	CcSEcCtD
Lansoprazole—Hyperhidrosis—Valproic Acid—migraine	0.000121	0.000486	CcSEcCtD
Lansoprazole—Rash—Propranolol—migraine	0.000121	0.000486	CcSEcCtD
Lansoprazole—Dermatitis—Propranolol—migraine	0.000121	0.000486	CcSEcCtD
Lansoprazole—Diarrhoea—Verapamil—migraine	0.00012	0.000485	CcSEcCtD
Lansoprazole—Connective tissue disorder—Topiramate—migraine	0.00012	0.000485	CcSEcCtD
Lansoprazole—Palpitations—Timolol—migraine	0.00012	0.000485	CcSEcCtD
Lansoprazole—Urethral disorder—Topiramate—migraine	0.00012	0.000484	CcSEcCtD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor—TNF—migraine	0.00012	0.0022	CbGpPWpGaD
Lansoprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	0.00012	0.0022	CbGpPWpGaD
Lansoprazole—Loss of consciousness—Timolol—migraine	0.00012	0.000482	CcSEcCtD
Lansoprazole—Vision blurred—Gabapentin—migraine	0.000119	0.000481	CcSEcCtD
Lansoprazole—Anorexia—Valproic Acid—migraine	0.000119	0.000479	CcSEcCtD
Lansoprazole—Cough—Timolol—migraine	0.000119	0.000478	CcSEcCtD
Lansoprazole—Tremor—Gabapentin—migraine	0.000119	0.000478	CcSEcCtD
Lansoprazole—Visual impairment—Topiramate—migraine	0.000118	0.000476	CcSEcCtD
Lansoprazole—Ill-defined disorder—Gabapentin—migraine	0.000118	0.000474	CcSEcCtD
Lansoprazole—Hypertension—Timolol—migraine	0.000118	0.000473	CcSEcCtD
Lansoprazole—Anaemia—Gabapentin—migraine	0.000117	0.000472	CcSEcCtD
Lansoprazole—Hypotension—Valproic Acid—migraine	0.000117	0.00047	CcSEcCtD
Lansoprazole—Agitation—Gabapentin—migraine	0.000117	0.000469	CcSEcCtD
Lansoprazole—Dizziness—Verapamil—migraine	0.000116	0.000469	CcSEcCtD
Lansoprazole—Arthralgia—Timolol—migraine	0.000116	0.000467	CcSEcCtD
Lansoprazole—Chest pain—Timolol—migraine	0.000116	0.000467	CcSEcCtD
Lansoprazole—Myalgia—Timolol—migraine	0.000116	0.000467	CcSEcCtD
Lansoprazole—Erythema multiforme—Topiramate—migraine	0.000116	0.000467	CcSEcCtD
Lansoprazole—Angioedema—Gabapentin—migraine	0.000116	0.000467	CcSEcCtD
Lansoprazole—Anxiety—Timolol—migraine	0.000116	0.000465	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000115	0.000464	CcSEcCtD
Lansoprazole—Discomfort—Timolol—migraine	0.000115	0.000461	CcSEcCtD
Lansoprazole—Eye disorder—Topiramate—migraine	0.000115	0.000461	CcSEcCtD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—HTR3A—migraine	0.000114	0.0021	CbGpPWpGaD
Lansoprazole—Malaise—Gabapentin—migraine	0.000114	0.00046	CcSEcCtD
Lansoprazole—Tinnitus—Topiramate—migraine	0.000114	0.00046	CcSEcCtD
Lansoprazole—MAPT—MAPK Signaling Pathway—TNF—migraine	0.000114	0.00209	CbGpPWpGaD
Lansoprazole—Vertigo—Gabapentin—migraine	0.000114	0.000459	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Valproic Acid—migraine	0.000114	0.000458	CcSEcCtD
Lansoprazole—Cardiac disorder—Topiramate—migraine	0.000114	0.000458	CcSEcCtD
Lansoprazole—Syncope—Gabapentin—migraine	0.000114	0.000458	CcSEcCtD
Lansoprazole—Nausea—Propranolol—migraine	0.000114	0.000458	CcSEcCtD
Lansoprazole—Leukopenia—Gabapentin—migraine	0.000113	0.000457	CcSEcCtD
Lansoprazole—Dry mouth—Timolol—migraine	0.000113	0.000457	CcSEcCtD
Lansoprazole—Insomnia—Valproic Acid—migraine	0.000113	0.000455	CcSEcCtD
Lansoprazole—Paraesthesia—Valproic Acid—migraine	0.000112	0.000451	CcSEcCtD
Lansoprazole—Palpitations—Gabapentin—migraine	0.000112	0.000451	CcSEcCtD
Lansoprazole—Confusional state—Timolol—migraine	0.000112	0.000451	CcSEcCtD
Lansoprazole—Vomiting—Verapamil—migraine	0.000112	0.000451	CcSEcCtD
Lansoprazole—Loss of consciousness—Gabapentin—migraine	0.000111	0.000449	CcSEcCtD
Lansoprazole—Dyspnoea—Valproic Acid—migraine	0.000111	0.000448	CcSEcCtD
Lansoprazole—Angiopathy—Topiramate—migraine	0.000111	0.000448	CcSEcCtD
Lansoprazole—Oedema—Timolol—migraine	0.000111	0.000448	CcSEcCtD
Lansoprazole—Anaphylactic shock—Timolol—migraine	0.000111	0.000448	CcSEcCtD
Lansoprazole—Rash—Verapamil—migraine	0.000111	0.000447	CcSEcCtD
Lansoprazole—Somnolence—Valproic Acid—migraine	0.000111	0.000447	CcSEcCtD
Lansoprazole—Dermatitis—Verapamil—migraine	0.000111	0.000447	CcSEcCtD
Lansoprazole—Immune system disorder—Topiramate—migraine	0.000111	0.000446	CcSEcCtD
Lansoprazole—Cough—Gabapentin—migraine	0.000111	0.000446	CcSEcCtD
Lansoprazole—Mediastinal disorder—Topiramate—migraine	0.00011	0.000445	CcSEcCtD
Lansoprazole—Infection—Timolol—migraine	0.00011	0.000445	CcSEcCtD
Lansoprazole—Headache—Verapamil—migraine	0.00011	0.000444	CcSEcCtD
Lansoprazole—Chills—Topiramate—migraine	0.00011	0.000443	CcSEcCtD
Lansoprazole—Dyspepsia—Valproic Acid—migraine	0.00011	0.000443	CcSEcCtD
Lansoprazole—Convulsion—Gabapentin—migraine	0.00011	0.000442	CcSEcCtD
Lansoprazole—Hypertension—Gabapentin—migraine	0.000109	0.000441	CcSEcCtD
Lansoprazole—Shock—Timolol—migraine	0.000109	0.00044	CcSEcCtD
Lansoprazole—Nervous system disorder—Timolol—migraine	0.000109	0.000439	CcSEcCtD
Lansoprazole—Decreased appetite—Valproic Acid—migraine	0.000108	0.000437	CcSEcCtD
Lansoprazole—Alopecia—Topiramate—migraine	0.000108	0.000436	CcSEcCtD
Lansoprazole—Chest pain—Gabapentin—migraine	0.000108	0.000435	CcSEcCtD
Lansoprazole—Arthralgia—Gabapentin—migraine	0.000108	0.000435	CcSEcCtD
Lansoprazole—Myalgia—Gabapentin—migraine	0.000108	0.000435	CcSEcCtD
Lansoprazole—Skin disorder—Timolol—migraine	0.000108	0.000435	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Valproic Acid—migraine	0.000108	0.000434	CcSEcCtD
Lansoprazole—Fatigue—Valproic Acid—migraine	0.000108	0.000433	CcSEcCtD
Lansoprazole—Anxiety—Gabapentin—migraine	0.000108	0.000433	CcSEcCtD
Lansoprazole—Hyperhidrosis—Timolol—migraine	0.000107	0.000433	CcSEcCtD
Lansoprazole—Mental disorder—Topiramate—migraine	0.000107	0.000432	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000107	0.000432	CcSEcCtD
Lansoprazole—Pain—Valproic Acid—migraine	0.000107	0.00043	CcSEcCtD
Lansoprazole—Constipation—Valproic Acid—migraine	0.000107	0.00043	CcSEcCtD
Lansoprazole—Erythema—Topiramate—migraine	0.000107	0.00043	CcSEcCtD
Lansoprazole—Malnutrition—Topiramate—migraine	0.000107	0.00043	CcSEcCtD
Lansoprazole—Discomfort—Gabapentin—migraine	0.000107	0.00043	CcSEcCtD
Lansoprazole—ABCG2—trigeminal ganglion—migraine	0.000106	0.028	CbGeAlD
Lansoprazole—Anorexia—Timolol—migraine	0.000106	0.000427	CcSEcCtD
Lansoprazole—Dry mouth—Gabapentin—migraine	0.000106	0.000425	CcSEcCtD
Lansoprazole—Flatulence—Topiramate—migraine	0.000105	0.000423	CcSEcCtD
Lansoprazole—Tension—Topiramate—migraine	0.000105	0.000422	CcSEcCtD
Lansoprazole—Nausea—Verapamil—migraine	0.000105	0.000421	CcSEcCtD
Lansoprazole—Dysgeusia—Topiramate—migraine	0.000104	0.000421	CcSEcCtD
Lansoprazole—Confusional state—Gabapentin—migraine	0.000104	0.00042	CcSEcCtD
Lansoprazole—Hypotension—Timolol—migraine	0.000104	0.000418	CcSEcCtD
Lansoprazole—Nervousness—Topiramate—migraine	0.000104	0.000417	CcSEcCtD
Lansoprazole—Anaphylactic shock—Gabapentin—migraine	0.000103	0.000417	CcSEcCtD
Lansoprazole—Oedema—Gabapentin—migraine	0.000103	0.000417	CcSEcCtD
Lansoprazole—Back pain—Topiramate—migraine	0.000103	0.000416	CcSEcCtD
Lansoprazole—CYP1B1—cardiovascular system—migraine	0.000103	0.0271	CbGeAlD
Lansoprazole—Feeling abnormal—Valproic Acid—migraine	0.000103	0.000414	CcSEcCtD
Lansoprazole—MAPT—Integrated Pancreatic Cancer Pathway—TNF—migraine	0.000103	0.00189	CbGpPWpGaD
Lansoprazole—Infection—Gabapentin—migraine	0.000103	0.000414	CcSEcCtD
Lansoprazole—Muscle spasms—Topiramate—migraine	0.000103	0.000413	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Valproic Acid—migraine	0.000102	0.000411	CcSEcCtD
Lansoprazole—Shock—Gabapentin—migraine	0.000102	0.00041	CcSEcCtD
Lansoprazole—Nervous system disorder—Gabapentin—migraine	0.000101	0.000409	CcSEcCtD
Lansoprazole—Thrombocytopenia—Gabapentin—migraine	0.000101	0.000408	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Timolol—migraine	0.000101	0.000408	CcSEcCtD
Lansoprazole—Tachycardia—Gabapentin—migraine	0.000101	0.000407	CcSEcCtD
Lansoprazole—Vision blurred—Topiramate—migraine	0.000101	0.000405	CcSEcCtD
Lansoprazole—Skin disorder—Gabapentin—migraine	0.000101	0.000405	CcSEcCtD
Lansoprazole—Insomnia—Timolol—migraine	0.0001	0.000405	CcSEcCtD
Lansoprazole—Hyperhidrosis—Gabapentin—migraine	0.0001	0.000403	CcSEcCtD
Lansoprazole—Tremor—Topiramate—migraine	9.99e-05	0.000402	CcSEcCtD
Lansoprazole—Paraesthesia—Timolol—migraine	9.98e-05	0.000402	CcSEcCtD
Lansoprazole—Urticaria—Valproic Acid—migraine	9.92e-05	0.000399	CcSEcCtD
Lansoprazole—Dyspnoea—Timolol—migraine	9.91e-05	0.000399	CcSEcCtD
Lansoprazole—Ill-defined disorder—Topiramate—migraine	9.9e-05	0.000399	CcSEcCtD
Lansoprazole—Somnolence—Timolol—migraine	9.88e-05	0.000398	CcSEcCtD
Lansoprazole—Abdominal pain—Valproic Acid—migraine	9.87e-05	0.000397	CcSEcCtD
Lansoprazole—Body temperature increased—Valproic Acid—migraine	9.87e-05	0.000397	CcSEcCtD
Lansoprazole—Anorexia—Gabapentin—migraine	9.86e-05	0.000397	CcSEcCtD
Lansoprazole—Anaemia—Topiramate—migraine	9.86e-05	0.000397	CcSEcCtD
Lansoprazole—Agitation—Topiramate—migraine	9.8e-05	0.000395	CcSEcCtD
Lansoprazole—Dyspepsia—Timolol—migraine	9.78e-05	0.000394	CcSEcCtD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—migraine	9.71e-05	0.00178	CbGpPWpGaD
Lansoprazole—Hypotension—Gabapentin—migraine	9.67e-05	0.000389	CcSEcCtD
Lansoprazole—Decreased appetite—Timolol—migraine	9.66e-05	0.000389	CcSEcCtD
Lansoprazole—Malaise—Topiramate—migraine	9.62e-05	0.000387	CcSEcCtD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—TRPM8—migraine	9.6e-05	0.00176	CbGpPWpGaD
Lansoprazole—Gastrointestinal disorder—Timolol—migraine	9.59e-05	0.000386	CcSEcCtD
Lansoprazole—Vertigo—Topiramate—migraine	9.58e-05	0.000386	CcSEcCtD
Lansoprazole—Fatigue—Timolol—migraine	9.58e-05	0.000386	CcSEcCtD
Lansoprazole—Syncope—Topiramate—migraine	9.56e-05	0.000385	CcSEcCtD
Lansoprazole—Leukopenia—Topiramate—migraine	9.55e-05	0.000385	CcSEcCtD
Lansoprazole—Pain—Timolol—migraine	9.5e-05	0.000383	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Gabapentin—migraine	9.43e-05	0.00038	CcSEcCtD
Lansoprazole—Palpitations—Topiramate—migraine	9.43e-05	0.00038	CcSEcCtD
Lansoprazole—Loss of consciousness—Topiramate—migraine	9.37e-05	0.000378	CcSEcCtD
Lansoprazole—Insomnia—Gabapentin—migraine	9.36e-05	0.000377	CcSEcCtD
Lansoprazole—Cough—Topiramate—migraine	9.31e-05	0.000375	CcSEcCtD
Lansoprazole—Paraesthesia—Gabapentin—migraine	9.29e-05	0.000374	CcSEcCtD
Lansoprazole—Convulsion—Topiramate—migraine	9.24e-05	0.000372	CcSEcCtD
Lansoprazole—Dyspnoea—Gabapentin—migraine	9.22e-05	0.000372	CcSEcCtD
Lansoprazole—Hypertension—Topiramate—migraine	9.21e-05	0.000371	CcSEcCtD
Lansoprazole—Somnolence—Gabapentin—migraine	9.2e-05	0.00037	CcSEcCtD
Lansoprazole—Hypersensitivity—Valproic Acid—migraine	9.2e-05	0.00037	CcSEcCtD
Lansoprazole—Feeling abnormal—Timolol—migraine	9.16e-05	0.000369	CcSEcCtD
Lansoprazole—Dyspepsia—Gabapentin—migraine	9.11e-05	0.000367	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Timolol—migraine	9.09e-05	0.000366	CcSEcCtD
Lansoprazole—Arthralgia—Topiramate—migraine	9.08e-05	0.000366	CcSEcCtD
Lansoprazole—Chest pain—Topiramate—migraine	9.08e-05	0.000366	CcSEcCtD
Lansoprazole—Myalgia—Topiramate—migraine	9.08e-05	0.000366	CcSEcCtD
Lansoprazole—Anxiety—Topiramate—migraine	9.05e-05	0.000364	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	9.02e-05	0.000363	CcSEcCtD
Lansoprazole—Decreased appetite—Gabapentin—migraine	8.99e-05	0.000362	CcSEcCtD
Lansoprazole—Discomfort—Topiramate—migraine	8.97e-05	0.000361	CcSEcCtD
Lansoprazole—Asthenia—Valproic Acid—migraine	8.95e-05	0.000361	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Gabapentin—migraine	8.93e-05	0.00036	CcSEcCtD
Lansoprazole—Fatigue—Gabapentin—migraine	8.92e-05	0.000359	CcSEcCtD
Lansoprazole—Dry mouth—Topiramate—migraine	8.88e-05	0.000358	CcSEcCtD
Lansoprazole—Constipation—Gabapentin—migraine	8.85e-05	0.000356	CcSEcCtD
Lansoprazole—Pain—Gabapentin—migraine	8.85e-05	0.000356	CcSEcCtD
Lansoprazole—Pruritus—Valproic Acid—migraine	8.83e-05	0.000356	CcSEcCtD
Lansoprazole—Urticaria—Timolol—migraine	8.83e-05	0.000356	CcSEcCtD
Lansoprazole—Abdominal pain—Timolol—migraine	8.78e-05	0.000354	CcSEcCtD
Lansoprazole—Body temperature increased—Timolol—migraine	8.78e-05	0.000354	CcSEcCtD
Lansoprazole—Confusional state—Topiramate—migraine	8.78e-05	0.000354	CcSEcCtD
Lansoprazole—Oedema—Topiramate—migraine	8.7e-05	0.000351	CcSEcCtD
Lansoprazole—Infection—Topiramate—migraine	8.65e-05	0.000348	CcSEcCtD
Lansoprazole—Shock—Topiramate—migraine	8.56e-05	0.000345	CcSEcCtD
Lansoprazole—Diarrhoea—Valproic Acid—migraine	8.54e-05	0.000344	CcSEcCtD
Lansoprazole—Nervous system disorder—Topiramate—migraine	8.54e-05	0.000344	CcSEcCtD
Lansoprazole—Feeling abnormal—Gabapentin—migraine	8.53e-05	0.000343	CcSEcCtD
Lansoprazole—Thrombocytopenia—Topiramate—migraine	8.52e-05	0.000343	CcSEcCtD
Lansoprazole—Tachycardia—Topiramate—migraine	8.5e-05	0.000342	CcSEcCtD
Lansoprazole—ABCB1—blood vessel—migraine	8.48e-05	0.0223	CbGeAlD
Lansoprazole—Gastrointestinal pain—Gabapentin—migraine	8.46e-05	0.000341	CcSEcCtD
Lansoprazole—Skin disorder—Topiramate—migraine	8.46e-05	0.000341	CcSEcCtD
Lansoprazole—Hyperhidrosis—Topiramate—migraine	8.42e-05	0.000339	CcSEcCtD
Lansoprazole—Anorexia—Topiramate—migraine	8.3e-05	0.000334	CcSEcCtD
Lansoprazole—Dizziness—Valproic Acid—migraine	8.25e-05	0.000332	CcSEcCtD
Lansoprazole—Urticaria—Gabapentin—migraine	8.22e-05	0.000331	CcSEcCtD
Lansoprazole—ABCB1—HIF-1-alpha transcription factor network—FOS—migraine	8.21e-05	0.00151	CbGpPWpGaD
Lansoprazole—Hypersensitivity—Timolol—migraine	8.19e-05	0.00033	CcSEcCtD
Lansoprazole—Body temperature increased—Gabapentin—migraine	8.18e-05	0.000329	CcSEcCtD
Lansoprazole—Abdominal pain—Gabapentin—migraine	8.18e-05	0.000329	CcSEcCtD
Lansoprazole—Hypotension—Topiramate—migraine	8.13e-05	0.000328	CcSEcCtD
Lansoprazole—Asthenia—Timolol—migraine	7.97e-05	0.000321	CcSEcCtD
Lansoprazole—Vomiting—Valproic Acid—migraine	7.94e-05	0.00032	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Topiramate—migraine	7.93e-05	0.000319	CcSEcCtD
Lansoprazole—Insomnia—Topiramate—migraine	7.87e-05	0.000317	CcSEcCtD
Lansoprazole—Rash—Valproic Acid—migraine	7.87e-05	0.000317	CcSEcCtD
Lansoprazole—Dermatitis—Valproic Acid—migraine	7.86e-05	0.000317	CcSEcCtD
Lansoprazole—Pruritus—Timolol—migraine	7.86e-05	0.000317	CcSEcCtD
Lansoprazole—Headache—Valproic Acid—migraine	7.82e-05	0.000315	CcSEcCtD
Lansoprazole—Paraesthesia—Topiramate—migraine	7.82e-05	0.000315	CcSEcCtD
Lansoprazole—CYP4A11—Metabolism—CACNA1A—migraine	7.77e-05	0.00143	CbGpPWpGaD
Lansoprazole—Dyspnoea—Topiramate—migraine	7.76e-05	0.000313	CcSEcCtD
Lansoprazole—Somnolence—Topiramate—migraine	7.74e-05	0.000312	CcSEcCtD
Lansoprazole—Dyspepsia—Topiramate—migraine	7.66e-05	0.000309	CcSEcCtD
Lansoprazole—Hypersensitivity—Gabapentin—migraine	7.62e-05	0.000307	CcSEcCtD
Lansoprazole—Diarrhoea—Timolol—migraine	7.6e-05	0.000306	CcSEcCtD
Lansoprazole—Decreased appetite—Topiramate—migraine	7.57e-05	0.000305	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Topiramate—migraine	7.52e-05	0.000303	CcSEcCtD
Lansoprazole—Fatigue—Topiramate—migraine	7.5e-05	0.000302	CcSEcCtD
Lansoprazole—Constipation—Topiramate—migraine	7.44e-05	0.0003	CcSEcCtD
Lansoprazole—Pain—Topiramate—migraine	7.44e-05	0.0003	CcSEcCtD
Lansoprazole—Asthenia—Gabapentin—migraine	7.42e-05	0.000299	CcSEcCtD
Lansoprazole—Nausea—Valproic Acid—migraine	7.41e-05	0.000299	CcSEcCtD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—migraine	7.38e-05	0.00135	CbGpPWpGaD
Lansoprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	7.38e-05	0.00135	CbGpPWpGaD
Lansoprazole—Dizziness—Timolol—migraine	7.35e-05	0.000296	CcSEcCtD
Lansoprazole—Pruritus—Gabapentin—migraine	7.32e-05	0.000295	CcSEcCtD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—ATP1A3—migraine	7.27e-05	0.00133	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—ATP1A2—migraine	7.27e-05	0.00133	CbGpPWpGaD
Lansoprazole—Feeling abnormal—Topiramate—migraine	7.17e-05	0.000289	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Topiramate—migraine	7.12e-05	0.000287	CcSEcCtD
Lansoprazole—Diarrhoea—Gabapentin—migraine	7.08e-05	0.000285	CcSEcCtD
Lansoprazole—Vomiting—Timolol—migraine	7.06e-05	0.000285	CcSEcCtD
Lansoprazole—CYP2C9—cardiovascular system—migraine	7.01e-05	0.0185	CbGeAlD
Lansoprazole—Rash—Timolol—migraine	7.01e-05	0.000282	CcSEcCtD
Lansoprazole—Dermatitis—Timolol—migraine	7e-05	0.000282	CcSEcCtD
Lansoprazole—CYP1B1—head—migraine	6.98e-05	0.0184	CbGeAlD
Lansoprazole—Headache—Timolol—migraine	6.96e-05	0.00028	CcSEcCtD
Lansoprazole—Urticaria—Topiramate—migraine	6.92e-05	0.000279	CcSEcCtD
Lansoprazole—Abdominal pain—Topiramate—migraine	6.88e-05	0.000277	CcSEcCtD
Lansoprazole—Body temperature increased—Topiramate—migraine	6.88e-05	0.000277	CcSEcCtD
Lansoprazole—Dizziness—Gabapentin—migraine	6.84e-05	0.000276	CcSEcCtD
Lansoprazole—CYP2C18—Metabolism—CACNA1A—migraine	6.79e-05	0.00125	CbGpPWpGaD
Lansoprazole—CYP1B1—nervous system—migraine	6.61e-05	0.0174	CbGeAlD
Lansoprazole—Nausea—Timolol—migraine	6.6e-05	0.000266	CcSEcCtD
Lansoprazole—Vomiting—Gabapentin—migraine	6.58e-05	0.000265	CcSEcCtD
Lansoprazole—Rash—Gabapentin—migraine	6.52e-05	0.000263	CcSEcCtD
Lansoprazole—Dermatitis—Gabapentin—migraine	6.52e-05	0.000263	CcSEcCtD
Lansoprazole—Headache—Gabapentin—migraine	6.48e-05	0.000261	CcSEcCtD
Lansoprazole—CYP2D6—brainstem—migraine	6.44e-05	0.017	CbGeAlD
Lansoprazole—Hypersensitivity—Topiramate—migraine	6.41e-05	0.000258	CcSEcCtD
Lansoprazole—CYP1B1—central nervous system—migraine	6.37e-05	0.0168	CbGeAlD
Lansoprazole—Asthenia—Topiramate—migraine	6.25e-05	0.000252	CcSEcCtD
Lansoprazole—CYP1B1—cerebellum—migraine	6.22e-05	0.0164	CbGeAlD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—HTR3A—migraine	6.18e-05	0.00113	CbGpPWpGaD
Lansoprazole—Pruritus—Topiramate—migraine	6.16e-05	0.000248	CcSEcCtD
Lansoprazole—Nausea—Gabapentin—migraine	6.15e-05	0.000248	CcSEcCtD
Lansoprazole—Diarrhoea—Topiramate—migraine	5.96e-05	0.00024	CcSEcCtD
Lansoprazole—Dizziness—Topiramate—migraine	5.76e-05	0.000232	CcSEcCtD
Lansoprazole—Vomiting—Topiramate—migraine	5.53e-05	0.000223	CcSEcCtD
Lansoprazole—Rash—Topiramate—migraine	5.49e-05	0.000221	CcSEcCtD
Lansoprazole—Dermatitis—Topiramate—migraine	5.48e-05	0.000221	CcSEcCtD
Lansoprazole—Headache—Topiramate—migraine	5.45e-05	0.00022	CcSEcCtD
Lansoprazole—ABCB1—trigeminal ganglion—migraine	5.24e-05	0.0138	CbGeAlD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	5.19e-05	0.000953	CbGpPWpGaD
Lansoprazole—Nausea—Topiramate—migraine	5.17e-05	0.000208	CcSEcCtD
Lansoprazole—CYP1B1—brain—migraine	5.05e-05	0.0133	CbGeAlD
Lansoprazole—CYP1B1—Metabolism—CACNA1A—migraine	5.01e-05	0.000919	CbGpPWpGaD
Lansoprazole—CYP1A1—head—migraine	4.93e-05	0.013	CbGeAlD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	4.7e-05	0.000863	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—migraine	4.7e-05	0.000863	CbGpPWpGaD
Lansoprazole—CYP1A1—nervous system—migraine	4.68e-05	0.0123	CbGeAlD
Lansoprazole—ABCG2—cerebellum—migraine	4.63e-05	0.0122	CbGeAlD
Lansoprazole—ABCG2—Metabolism—CACNA1A—migraine	4.56e-05	0.000836	CbGpPWpGaD
Lansoprazole—CYP1A1—central nervous system—migraine	4.5e-05	0.0119	CbGeAlD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	3.89e-05	0.000715	CbGpPWpGaD
Lansoprazole—CYP2C8—brain—migraine	3.87e-05	0.0102	CbGeAlD
Lansoprazole—ABCB1—Allograft Rejection—TNF—migraine	3.82e-05	0.000702	CbGpPWpGaD
Lansoprazole—ABCB1—cardiovascular system—migraine	3.78e-05	0.00997	CbGeAlD
Lansoprazole—ABCG2—brain—migraine	3.76e-05	0.00992	CbGeAlD
Lansoprazole—CYP1A1—brain—migraine	3.57e-05	0.00942	CbGeAlD
Lansoprazole—CYP2D6—head—migraine	3.56e-05	0.00938	CbGeAlD
Lansoprazole—CYP3A4—nervous system—migraine	3.43e-05	0.00904	CbGeAlD
Lansoprazole—CYP2D6—nervous system—migraine	3.38e-05	0.0089	CbGeAlD
Lansoprazole—CYP3A4—central nervous system—migraine	3.3e-05	0.0087	CbGeAlD
Lansoprazole—CYP2D6—central nervous system—migraine	3.25e-05	0.00856	CbGeAlD
Lansoprazole—CYP2D6—cerebellum—migraine	3.18e-05	0.00837	CbGeAlD
Lansoprazole—CYP1A1—Metabolism—CACNA1A—migraine	3.08e-05	0.000566	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CACNA1A—migraine	2.83e-05	0.000519	CbGpPWpGaD
Lansoprazole—CYP2D6—brain—migraine	2.58e-05	0.0068	CbGeAlD
Lansoprazole—CYP4A11—Metabolism—MTHFR—migraine	2.57e-05	0.000472	CbGpPWpGaD
Lansoprazole—ABCB1—head—migraine	2.56e-05	0.00675	CbGeAlD
Lansoprazole—CYP2C19—Metabolism—CACNA1A—migraine	2.52e-05	0.000463	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CACNA1A—migraine	2.46e-05	0.000452	CbGpPWpGaD
Lansoprazole—ABCB1—nervous system—migraine	2.43e-05	0.0064	CbGeAlD
Lansoprazole—ABCB1—central nervous system—migraine	2.34e-05	0.00616	CbGeAlD
Lansoprazole—CYP2D6—Metabolism—CACNA1A—migraine	2.32e-05	0.000426	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CACNA1A—migraine	2.3e-05	0.000422	CbGpPWpGaD
Lansoprazole—ABCB1—cerebellum—migraine	2.29e-05	0.00602	CbGeAlD
Lansoprazole—CYP2C18—Metabolism—MTHFR—migraine	2.25e-05	0.000412	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CACNA1A—migraine	1.97e-05	0.000361	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	1.89e-05	0.000346	CbGpPWpGaD
Lansoprazole—ABCB1—brain—migraine	1.86e-05	0.00489	CbGeAlD
Lansoprazole—CYP1B1—Metabolism—MTHFR—migraine	1.66e-05	0.000304	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CACNA1A—migraine	1.52e-05	0.000278	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—MTHFR—migraine	1.51e-05	0.000277	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—MTHFR—migraine	1.02e-05	0.000187	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—MTHFR—migraine	9.35e-06	0.000172	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—MTHFR—migraine	8.35e-06	0.000153	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—MTHFR—migraine	8.15e-06	0.00015	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—MTHFR—migraine	7.68e-06	0.000141	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—MTHFR—migraine	7.61e-06	0.00014	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—MTHFR—migraine	6.5e-06	0.000119	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—MTHFR—migraine	5.02e-06	9.21e-05	CbGpPWpGaD
